Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 2,161 shares at $13.64 ($29K) on 2026-07-02, disclosed to the SEC on 2026-07-06.
Scheduled sale ($29k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |
| RGNX | SELL | 2024-01-04 | $600K | — | Filing → |